VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,073 | -100.0% | 300 | -100.0% | 0.00% | -100.0% |
Q2 2023 | $20,282,096 | -81.1% | 673,600 | -77.4% | 0.15% | -93.6% |
Q4 2020 | $107,552,000 | +171.0% | 2,985,900 | +100.9% | 2.40% | +138.1% |
Q3 2019 | $39,688,000 | +3504.7% | 1,485,900 | +3350.6% | 1.01% | +5205.3% |
Q2 2019 | $1,101,000 | +80.2% | 43,062 | +58.0% | 0.02% | +46.2% |
Q1 2019 | $611,000 | -1.6% | 27,256 | -7.5% | 0.01% | 0.0% |
Q4 2018 | $621,000 | -38.8% | 29,456 | -46.3% | 0.01% | -27.8% |
Q3 2018 | $1,015,000 | -47.3% | 54,813 | -36.5% | 0.02% | -51.4% |
Q2 2018 | $1,927,000 | -0.8% | 86,385 | -2.3% | 0.04% | +5.7% |
Q1 2018 | $1,943,000 | -5.5% | 88,388 | -0.1% | 0.04% | +2.9% |
Q4 2017 | $2,056,000 | -41.9% | 88,485 | -42.6% | 0.03% | -50.0% |
Q3 2017 | $3,538,000 | -30.0% | 154,100 | -32.7% | 0.07% | -29.9% |
Q2 2017 | $5,054,000 | -13.5% | 228,915 | -10.6% | 0.10% | -8.5% |
Q1 2017 | $5,842,000 | +2354.6% | 256,100 | +2777.5% | 0.11% | +3433.3% |
Q3 2016 | $238,000 | – | 8,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |